Pick the drugs you want to compare.
Start with the molecules your plan spends the most on. Most useful comparisons live within the same therapeutic class — switching across classes requires deeper clinical review.
Drug 1
Drug 2
Drug 3 (optional)
Drug 4 (optional)
Side by side, line by line.
Compare across
11 dimensions
Lowest NADACAcquisition cost floor across all NDCs
$0.162Per unit
$0.162Per unit
Average NADACAcross all dosage forms and strengths
$0.182Up to $0.242
$0.838Up to $5.07
Generic manufacturersActive ANDA holders — FDA Orange Book
00 total ANDAs filed
1016 total ANDAs filed
Annualized Part D spendCY2024 — CMS Part D Spending Dashboard
—Full year
$41.4MFull year
Part D claims (CY24)Total fills, all strengths
—— beneficiaries
2.0M623K beneficiaries
Avg cost per claimCalculated: total spend ÷ total claims
—Per claim, all NDCs
$21Per claim, all NDCs
Part D plans surveyed2026 plan year — CMS Formulary file
329Across CMS plan year
329Across CMS plan year
Prior-authorization frictionPlan-NDC pairs requiring PA
—Zero PA friction
198Substantial friction
Step therapy appliedPlan-NDC pairs requiring step therapy
—None
2Limited friction
FDA shortage statusLive cross-reference vs FDA Drug Shortage Database
NoneClear
DiscontinuedSee drug profile
Generic availableFDA Orange Book
NoBrand-only
Yes10 manufacturers